PL328135A1 - Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers - Google Patents

Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers

Info

Publication number
PL328135A1
PL328135A1 PL97328135A PL32813597A PL328135A1 PL 328135 A1 PL328135 A1 PL 328135A1 PL 97328135 A PL97328135 A PL 97328135A PL 32813597 A PL32813597 A PL 32813597A PL 328135 A1 PL328135 A1 PL 328135A1
Authority
PL
Poland
Prior art keywords
centchromane
enantiomer
preventing
production
application
Prior art date
Application number
PL97328135A
Other languages
English (en)
Inventor
Michael Shalmi
Ved Prakash Kamboj
Omkar Prasad Asthana
Suprabhat Ray
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL328135A1 publication Critical patent/PL328135A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL97328135A 1996-01-11 1997-01-09 Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers PL328135A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1000096P 1996-01-11 1996-01-11
DK77696 1996-07-11
PCT/DK1997/000007 WO1997025034A1 (fr) 1996-01-11 1997-01-09 Utilisation de l'enantiomere-l de centchromanne dans la fabrication d'une composition pharmaceutique servant au traitement ou a la prophylaxie du cancer du sein

Publications (1)

Publication Number Publication Date
PL328135A1 true PL328135A1 (en) 1999-01-18

Family

ID=26064631

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328135A PL328135A1 (en) 1996-01-11 1997-01-09 Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers

Country Status (12)

Country Link
EP (1) EP0873119A1 (fr)
JP (1) JP2001500101A (fr)
KR (1) KR19990077157A (fr)
AU (1) AU1367197A (fr)
BR (1) BR9706966A (fr)
CA (1) CA2241462A1 (fr)
CZ (1) CZ217198A3 (fr)
HU (1) HUP9901633A3 (fr)
IL (1) IL124881A0 (fr)
NO (1) NO983177L (fr)
PL (1) PL328135A1 (fr)
WO (1) WO1997025034A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1143899A (en) * 1997-11-10 1999-05-31 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2011253842B2 (en) * 1998-06-11 2014-08-14 Endorecherche Inc. Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
AU2004200099B2 (en) * 1998-06-11 2006-11-02 Endorecherche, Inc. Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
CA2749235C (fr) 2004-10-20 2014-08-12 Endorecherche, Inc. Precurseurs de steroide sexuel, seuls ou combines a un modulateur de recepteur d'oestrogene selectif et/ou a des oestrogenes et/ou a un inhibiteur de phosphodiesterase de type 5 cgmp, pour prevenir et traiter la secheresse vaginale et les dysfonctionnements sexuels chez la femme postmenopausee
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
ME00996B (fr) 2007-10-16 2012-10-20 Repros Therapeutics Inc Traitement d'un syndrome métabolique par trans-clomiphène
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
MX2012014579A (es) 2010-06-16 2013-05-22 Endorech Inc Procedimientos de tratamiento o pevencion de enfermedades relacionadas con estrogenos.
US20150031656A1 (en) 2012-02-29 2015-01-29 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
US11633382B2 (en) 2015-11-10 2023-04-25 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof

Also Published As

Publication number Publication date
CZ217198A3 (cs) 1998-11-11
NO983177L (no) 1998-07-10
HUP9901633A2 (hu) 1999-10-28
EP0873119A1 (fr) 1998-10-28
BR9706966A (pt) 1999-05-04
AU1367197A (en) 1997-08-01
HUP9901633A3 (en) 2000-02-28
IL124881A0 (en) 1999-01-26
CA2241462A1 (fr) 1997-07-17
WO1997025034A1 (fr) 1997-07-17
JP2001500101A (ja) 2001-01-09
KR19990077157A (ko) 1999-10-25

Similar Documents

Publication Publication Date Title
EP0718099A3 (fr) Machine rotative pour gaufrer
PL323128A1 (en) Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
PL323130A1 (en) Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
EP0973396A4 (fr) Procede de traitement du cancer
GB9801231D0 (en) A method of treating cancer
PL328135A1 (en) Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers
EP0703282A3 (fr) Composition de traitement de surface
GB2325421B (en) Process for coating surgical needles
EP0742849A4 (fr) Agent de traitement de surface pour acier zingue
EP1075533A4 (fr) Composes anticancereux a petites molecules et leurs procedes de production
PL327505A1 (en) Production of biscyclopentadienylodiene complexes
TW458159U (en) Continuous unloading machine
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
GB9614476D0 (en) Rotary machine
HUP9601972A3 (en) Rotary machine
GB9708204D0 (en) Tablet coating machine
TW348787U (en) Profiled cylinder for teaseling and/or fluffing machines
EP1007041A4 (fr) Composition analgesique
GB2323057B (en) Finishing machine for foil and plate manufacture
GB2322151B (en) Synthetic surface treatment apparatus
HU9601450D0 (en) Process for producing pharmaceutical composition for treating neoplasmic syndromas
EP1019529A4 (fr) Procede pour le traitement du cancer
GB9502504D0 (en) Tunnelling machine
SG101918A1 (en) Tableting process and tableting machine
HUP9602110A3 (en) Pharmaceutical composition for treating prostatismus benignus and chronic prostatitis, and process for producing said composition